Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 27 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Allo-hMSCs | - | - | - | - | 2件: 211 211, 299 💬
| |||||||||||||||||||||||||||||||||
| 2 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬2. Ambrisentan
| 1件: EDNRA EDNRA 💬2. Ambrisentan
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin se ... | 7件: 51 51, 84, 85, 86, 88, 210, 211 💬
| |||||||||||||||||||||||||||||||||
| 3 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 💬3. Autologous (self) mononuclear cells derived from umbilical cord blood
| |||||||||||||||||||||||||||||||||
| 4 | Autologous cardiac stem cells (JRM-001) | - | - | - | - | 2件: 210 210, 211 💬
| |||||||||||||||||||||||||||||||||
| 5 | Autologous cell-based delivery | - | - | - | - | 1件: 211 211 💬5. Autologous cell-based delivery
| |||||||||||||||||||||||||||||||||
| 6 | Autologous Umbilical Cord Blood | - | - | - | - | 2件: 211 211, 294 💬
| |||||||||||||||||||||||||||||||||
| 7 | Bosentan | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,Bosentan 💬 | 2件: EDNRA EDNRA,EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬7. Bosentan
| |||||||||||||||||||||||||||||||||
| 8 | C-kit+ cells | - | - | - | - | 1件: 211 211 💬8. C-kit+ cells
| |||||||||||||||||||||||||||||||||
| 9 | Cardiac progenitor cell infusion | - | - | - | - | 2件: 210 210, 211 💬
| |||||||||||||||||||||||||||||||||
| 10 | Curosurf | 1件: Poractant alfa Poractant alfa | 1件: Poractant alfa
Poractant alfa
💬10. Curosurf
| - | - | 1件: 211 211 💬10. Curosurf
|